Inspire Medical Systems Inc（INSP）财务数据INSPInspire Medical Systems Inc

Evaluating the bottom line, Inspire Medical Systems, Inc. maintains a gross margin of 85.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -0.26%, while the net margin is 0.16%. These profitability ratios, combined with a Return on Equity (ROE) of 17.96%, provide a clear picture of how effectively INSP converts its operational activities into shareholder value.

In the context of the broader market, INSP competes directly with industry leaders such as BLFS and BWAY. With a market capitalization of $1.65B, it holds a significant position in the sector. When comparing efficiency, INSP's gross margin of 85.48% stands against BLFS's 63.69% and BWAY's 75.17%. Such benchmarking helps identify whether Inspire Medical Systems, Inc. is trading at a premium or discount relative to its financial performance.

In Q2 2026, Inspire reported total revenue of $200.6 million, which was above market expectations, and a gross margin of 85.48%, reflecting strong operational efficiency. The company also has a solid cash position with $415 million in cash and no debt, providing a strong financial foundation for growth.